Cancer is Personal
Bringing the Promise of Personalized Medicine to Reality
Our unique molecular information platform identifies the biomarkers of a living tumor using a set of genomic and functional tests that determine how a specific tumor responds to drugs. We then compare your personal tumor profile with our extensive knowledgebase generating a roadmap for your oncologist to personalize your treatment.
Improving Patient Outcomes
Every tumor we test contributes data to our unique D-CHIP knowledgebase which contains anonymized molecular and drug response profiles from over 150,000 cancer cases. Using the proven power of Artificial Intelligence (AI) we are leveraging this data to build predictive models of tumor drug response. These molecular diagnostics models offer researchers in pharma, biopharma and diagnostic companies actionable insights to drive the development of new precision therapies, companion diagnostics, biomarkers, and help design better targeted trials – all with the potential of dramatically improving patient outcomes.
Visit the Helomics website for more information: https://www.helomics.com/